Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Obtain critical industry information covering new biosimilars launches, information, company strategies, and new biosimilars product development.
60 Total results for product and free and sample content found
12 Oct 2021
India leads the ways with the highest number of approved biosimilars.
Topic clinical-trials biosimilars
05 Mar 2021
London – 5 March, 2021 – Planning is underway for the 2021 Global Generics & Biosimilars Awards. The awards, now in their eighth year, celebrate successes across the generics, biosimilars, and value-added medicines industries.
Topic biosimilars press-release
27 Nov 2020
Having seen its development partner Bioeq file with the FDA in December last year, Coherus is confident that it will be a leader in the US biosimilar ranibizumab market targeting Lucentis.
Topic biosimilars deal-trends
27 Nov 2020
Celltrion says it is ready to roll out its Remsima SC subcutaneous infliximab in Europe in the first quarter of 2020, after receiving a formal pan-European marketing authorization from the European Commission.
Topic biosimilars Launches Regulation
27 Nov 2020
It is important to understand how the biosimilar market has developed over the past five years. Take a look at some of the key events here.
Topic biosimilars
By David Wallace 27 Nov 2020
Alberta has become the second Canadian province to announce a biosimilar switching program, following the example set by British Columbia earlier this year. The move has been welcomed by Biosimilars Canada but criticized by originator-backed body Crohn’s and Colitis Canada.
Topic biosimilars Regulation
By Akriti Seth 17 Nov 2020
Pfizer has reported 80% growth in its global biosimilars business for the third quarter of 2020, on the back of recent oncology launches. Though the company’s sterile injectables saw a slight drop in business, Pfizer’s biopharma business saw 4% growth.
21 Sep 2020
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in move towards increasing biosimilar uptake.
Topic EU biosimilars
By C+D Data 09 Sep 2020
Chemist + Druggist has expanded its “PIP code” system for UK pharmacy procurement to also encompass hospital drugs.
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
